// App-Quantinova.ai

418.0 : Effect of cytoreductive surgery and HIPEC on survival in comparison to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.

Researchers

Presenter

  • Frederic Mercier

Principal Investigators

  • David L. Bartlett

  • Edward Allen Levine

  • Dario Baratti

  • Pompiliu Piso

  • David L. Morris

  • Beate Rau

  • Antonios Apostolos K Tentes

  • Jean-Jacques Tuech

  • Francois Quenet

  • Eduardo Hiroshi Akaishi

  • Marc Pocard

  • Yutaka Yonemura

  • Gerard Lorimier

  • Delphine Delroeux

  • Laurent Villeneuve

  • Olivier Glehen

  • Guillaume Passot

Medical Centers

  • Hopital Notre-Dame, CHUM, Montreal, QC, Canada

  • CHU Lyon Sud, Lyon, France.

  • University of Pittsburgh Medical Center, Pittsburgh, PA

  • Wake Forest University, Winston-Salem, NC

  • Istituto Nazionale per la Cura e lo Studio dei Tumori, Milan, Italy

  • University of Heidelberg Medical Center, Heidelberg, Germany

  • The University of New South Wales, NSW, Australia

  • Charite Campus Mitte University of Berlin, Berlin, Germany

  • Didimotichon General Hospital, Athens, Greece

  • CHU Charles Nicolle Rouen, Rouen, France

  • Institut du Cancer de Montpellier, Montpellier, France

  • Instituto do Cancer do Estado de Sao Paulo - ICESP, Sao Paulo, Brazil

  • Hopital Lariboisiere AP-HP, Service de Chirurgie Digestie et Cancerologie, Paris, France

  • NPO Organization to Support Peritoneal Dissemination Treatment, Osaka, Japan

  • Institut de Cancerologie de lOuest - Departement dOncologie Chirurgicale, Angers, France

  • CHU Besancon, Besancon, France

  • Hospice Civils Lyon Unite Rechercher Clinique Pole Information Medicale, Lyon, France

  • Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Benite, France

  • Centre Hospitalo-Universitaire Lyon Sud, Lyon, France

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Twist-related protein 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A